CompletedNCT02008773
Valacyclovir Added to Treatment for Thinking Skills in Early Schizophrenia
About this title
Read the official source — NCT02008773Medication studyAges 18–40United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 40 years.
- Listed locations
- Bellflower and 12 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: March 26, 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 170
- Sponsor
- Indiana University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT02008773
- Official title
Show the full official title
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bellflower · Los Angeles · Riverside
9 more locations
- Santa Ana
- New Haven
- Lauderhill
- Indianapolis
- Wichita
- Baltimore
- Rockville
- Towson
- Tulsa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Indiana University, a university.
Did this study involve medication?
Yes. The study involved medication, including Valacyclovir HCI 500 mg tablets and placebo.
Who was this study for?
Listed age limits: 18 years to 40 years.
